em 16 has been researched along with 2-(2,6-dioxopiperidin-3-yl)phthalimidine in 1 studies
| Studies (em 16) | Trials (em 16) | Recent Studies (post-2010) (em 16) | Studies (2-(2,6-dioxopiperidin-3-yl)phthalimidine) | Trials (2-(2,6-dioxopiperidin-3-yl)phthalimidine) | Recent Studies (post-2010) (2-(2,6-dioxopiperidin-3-yl)phthalimidine) |
|---|---|---|---|---|---|
| 5 | 0 | 3 | 21 | 0 | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Klinkmüller, KD; Schmahl, HJ; Winckler, K | 1 |
1 other study(ies) available for em 16 and 2-(2,6-dioxopiperidin-3-yl)phthalimidine
| Article | Year |
|---|---|
Determination of the thalidomide analogues 2-(2,6-dioxopiperidine-3-yl)phthalimidine (EM 12), 2-(2,6-dioxopiperidine-4-yl)phthalimidine (EM 16) and their metabolites in biological samples.
Topics: Animals; Callitrichinae; Chemical Phenomena; Chemistry; Chromatography, High Pressure Liquid; Rats; Rats, Inbred Strains; Spectrophotometry, Ultraviolet; Thalidomide | 1989 |